Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Transcranial Direct Current Stimulation Tdcs Eldith Dc Neuroconn Stimulator

Research Leaders

7 sponsors active, led by Centre Hospitalier Universitaire de Besancon

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total

Phase 2 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials

NCT01644747Phase 2CompletedPrimary

tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients

Showing all 1 trials

Research Network

Common Treatments

Transcranial Direct Current Stimulation Tdcs Eldith Dc Neuroconn Stimulator1

Active Sponsors

Centre Hospitalier Universitaire de Besancon1
Hôpital Civil de Strasbourg - Service de Psychiatrie (Pr G.Bertschy)1
CH Le Vinatier - Service de Psychiatrie (Dr Emmanuel POULET)1
Clinical Investigation Centre for Innovative Technology Network1
EPS Ville-Evrard - Unité de Recherche Clinique (Dr Dominique JANUEL)1

Resistant Depression